Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.
Expert Interviews
Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.
Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.
Caroline Pearson, executive director of the Peterson Center on Healthcare, explains a new analysis of use and payment for remote monitoring technologies.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
Compounded GLP-1 RA drugs: Are GLP-1 RA drugs the biggest phenomenon in American health care? Part 1
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
Joshua M. Liao, MD, spoke with Medical Economics following the ACP Internal Medicine Meeting last month about succeeding in value-based payment models.
Expert physicians discuss the urgent need to rebuild trust in vaccines amid rising skepticism and misinformation during the Trump administration, emphasizing the role of physicians in public health.
Joshua M. Liao, MD, outlines three critical factors primary care physicians should consider when deciding between value-based care models.
Joshua M. Liao, MD, explains how practices can effectively include non-clinical staff in performance incentives.
Joshua M. Liao discusses how primary care practices can adapt to models that reward care delivered outside traditional office visits.
Joshua M. Liao, MD, offers advice for practices trying to keep patients engaged and connected in a fragmented care environment.
Joshua M. Liao, MD, discusses the importance of patient attribution in value-based payment models — and how small practices can get it right.
AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.
AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.
AI tools are becoming more prevalent in back office operations, but they are also making inroads on the diagnostic side.
Advertisement
Advertisement
